FindTrial
Sign In

The study of biomarkers on the early warning and prognosis of moderate and severe traumatic brain injury in children

The study of biomarkers on the early warning and prognosis of moderate and severe traumatic brain injury in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065505
Enrollment
Unknown
Registered
2022-11-07
Start date
2022-11-18
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Interventions

Brain injury group:N/A
Normal group:N/A

Sponsors

Children’s Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children with traumatic brain injury, age from 28 days to 18 years, GCS<= 13

Exclusion criteria

Exclusion criteria: Combined with hemophilia, tumor, congenital metabolic disease, immune function defect or severe extracranial disease.

Design outcomes

Primary

MeasureTime frame
mortality;Galactooligosaccharides;the length of hospital stay;the length of Mechanical Ventilation;the length of ICU stay;NF-H;Ubiquitin C-terminal hydrolase L1;Tau;vascular cellular adhesion molecule-1;glial fibrillary acidic protein;IL-6;Il-8;TNF-a;IL-17A;—

Countries

China

Contacts

Public ContactYueqiang Fu

Children's Hospital of Chongqing Medical University

fuyueqiang@sina.com+86 23 63630685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026